Back to Clinical Trials
NCT03668431
Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
Unknown
Phase 2
Description
This research study is studying a combination of drugs as a possible treatment for metastatic colorectal cancer characterized by BRAF V600E mutation.
The names of the study drugs involved in this study are:
* Dabrafenib
* Trametinib
* PDR001
The names of the study drugs involved in this study are:
* Dabrafenib
* Trametinib
* PDR001
Trial Information
NCT03668431
Unknown
Phase 2
Oct 2018